Phase 1 Overweight/Obesity Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults

Overweight/Obesity

iBio, Inc.32 enrolled1 locationNCT07487376

Recruiting

Phase 1

A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

Overweight/Obesity

Beijing QL Biopharmaceutical Co.,Ltd40 enrolled3 locationsNCT07443059

Recruiting

Phase 1

Bioequivalence Study of BGM0504 Injection

Overweight/Obesity

BrightGene Bio-Medical Technology Co., Ltd.144 enrolled1 locationNCT07382908